Wang Reflects on Ibrutinib’s Role and Emerging Research in MCL Management

Season 6 Episode 27  ·  Jan 20, 2022, 10:33 PM

Headliner
Share
Subscribe

Dr Wang discusses the clinical experience with ibrutinib in mantle cell lymphoma, its present role in the management of MCL, and ongoing research that may affect its use as a single agent.

Share
Subscribe
Next
Sorting Through Sexism, Guilt, and Motherhood in Medicine
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air